東華大學圖書館 |

Mapping the Whole-Brain Response to Noninvasive Neuromodulation : = from Rodents to Humans.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Mapping the Whole-Brain Response to Noninvasive Neuromodulation :/
其他題名:	from Rodents to Humans.
作者:	Wang, Jeffrey Bond.
面頁冊數:	1 online resource (139 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-04, Section: A.
Contained By:	Dissertations Abstracts International85-04A.
標題:	Gene therapy. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30615148click for full text (PQDT)
ISBN:	9798380484954

Mapping the Whole-Brain Response to Noninvasive Neuromodulation : = from Rodents to Humans.
Wang, Jeffrey Bond.

Mapping the Whole-Brain Response to Noninvasive Neuromodulation :from Rodents to Humans. - 1 online resource (139 pages)

Source: Dissertations Abstracts International, Volume: 85-04, Section: A.

Thesis (Ph.D.)--Stanford University, 2023.

Includes bibliographical references

Because of recent advances in electrophysiology and imaging, we are now capable of recording intracranial neurologic activity at an unprecedented scale in terms of both spatiotemporal resolution and dimensionality. However, there still remains very few clinically translatable technologies for noninvasive neuromodulations to be able to causally perturb map functional networks within the brain, nor analysis techniques to leverage whole-brain intracranial data to gain insight into the relationship between CNS and peripheral physiology. In this dissertation, we present the novel use of ultrasonic drug uncaging for spatiotemporally precise noninvasive neuromodulation, in-human characterization of the whole-brain effects of Transcranial Magnetic Stimulation (TMS), and the application of machine learning to decode peripheral metabolic activity from intracranial electrophysiology.First, we develop biocompatible and clinically-translatable nanoparticles that enable ultrasoundinduced uncaging of neuromodulatory drugs noninvasively within millimeter-sized brain regions. Utilizing the anesthetic propofol together with electrophysiological and imaging assays, we show that the neuromodulatory effect of ultrasonic drug uncaging is limited spatially and temporally by the size of the ultrasound focus, the sonication timing, and the pharmacokinetics of the uncaged drug. Moreover, we see secondary effects in brain regions anatomically distinct from and functionally connected to the sonicated region, indicating that ultrasonic drug uncaging could noninvasively map the changes in functional network connectivity associated with pharmacologic action at a particular brain target.We then present the first in-human study of the effect of TMS across the human brain using intracranial electrophysiology. With this technology, we show for the first time that single pulses of TMS delivered to the dorsolateral prefrontal cortex can elicit evoked potentials not only at the direct stimulation site, but also recruits downstream activity within the saliency network via the anterior cingulate cortex. These findings provide mechanistic explanation for TMS's efficacy in treating depression, while also exhibiting the potential for intracranial EEG to map the whole-brain effect of noninvasive neuromodulation in humans.Finally, we show that intracranial electrophysiology can proactively decode peripheral metabolic activity (i.e. serum glucose levels) up to hours into the future. In three human subjects, we simultaneously measured interstitial glucose concentrations and local field potentials from cortical and subcortical regions, including the hypothalamus in one subject. Correlations between high frequency activity (HFA, 70-170 Hz) and peripheral glucose levels were found across multiple brain regions, notably in the hypothalamus. With machine learning, we then show that spectro-spatial features of neural activity enable decoding of peripheral glucose levels both in the present and up to hours in the future. Our findings demonstrate proactive encoding of homeostatic glucose dynamics by the CNS and highlight the possibility of using intracranial electrophysiology to decode peripheral physiologic states.In summary, we show that noninvasive neuromodulation, whether by ultrasonic drug uncaging or TMS, exerts significant effects across entire brain networks in a predictable manner. We also leverage machine learning tools to show that intracranial activity can proactively decode physiologic parameters. Our hope is that these findings can be translated to advance noninvasive neuromodulation for treating both neuropsychiatric conditions and other diseases.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798380484954Subjects--Topical Terms:

600619
Gene therapy.
Index Terms--Genre/Form:

542853
Electronic books.

Mapping the Whole-Brain Response to Noninvasive Neuromodulation : = from Rodents to Humans.
LDR:05104nmm a2200445K 4500 001 2363087
005 20231109104756.5
006 m o d
007 cr mn ---uuuuu
008 241011s2023 xx obm 000 0 eng d
020 $a 9798380484954
035 $a (MiAaPQ)AAI30615148
035 $a (MiAaPQ)STANFORDyg257gp4550
035 $a AAI30615148
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Wang, Jeffrey Bond. $3 3703835
245 1 0 $a Mapping the Whole-Brain Response to Noninvasive Neuromodulation : $b from Rodents to Humans.
264 0 $c 2023
300 $a 1 online resource (139 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-04, Section: A.
500 $a Advisor: Airan, Raag.
502 $a Thesis (Ph.D.)--Stanford University, 2023.
504 $a Includes bibliographical references
520 $a Because of recent advances in electrophysiology and imaging, we are now capable of recording intracranial neurologic activity at an unprecedented scale in terms of both spatiotemporal resolution and dimensionality. However, there still remains very few clinically translatable technologies for noninvasive neuromodulations to be able to causally perturb map functional networks within the brain, nor analysis techniques to leverage whole-brain intracranial data to gain insight into the relationship between CNS and peripheral physiology. In this dissertation, we present the novel use of ultrasonic drug uncaging for spatiotemporally precise noninvasive neuromodulation, in-human characterization of the whole-brain effects of Transcranial Magnetic Stimulation (TMS), and the application of machine learning to decode peripheral metabolic activity from intracranial electrophysiology.First, we develop biocompatible and clinically-translatable nanoparticles that enable ultrasoundinduced uncaging of neuromodulatory drugs noninvasively within millimeter-sized brain regions. Utilizing the anesthetic propofol together with electrophysiological and imaging assays, we show that the neuromodulatory effect of ultrasonic drug uncaging is limited spatially and temporally by the size of the ultrasound focus, the sonication timing, and the pharmacokinetics of the uncaged drug. Moreover, we see secondary effects in brain regions anatomically distinct from and functionally connected to the sonicated region, indicating that ultrasonic drug uncaging could noninvasively map the changes in functional network connectivity associated with pharmacologic action at a particular brain target.We then present the first in-human study of the effect of TMS across the human brain using intracranial electrophysiology. With this technology, we show for the first time that single pulses of TMS delivered to the dorsolateral prefrontal cortex can elicit evoked potentials not only at the direct stimulation site, but also recruits downstream activity within the saliency network via the anterior cingulate cortex. These findings provide mechanistic explanation for TMS's efficacy in treating depression, while also exhibiting the potential for intracranial EEG to map the whole-brain effect of noninvasive neuromodulation in humans.Finally, we show that intracranial electrophysiology can proactively decode peripheral metabolic activity (i.e. serum glucose levels) up to hours into the future. In three human subjects, we simultaneously measured interstitial glucose concentrations and local field potentials from cortical and subcortical regions, including the hypothalamus in one subject. Correlations between high frequency activity (HFA, 70-170 Hz) and peripheral glucose levels were found across multiple brain regions, notably in the hypothalamus. With machine learning, we then show that spectro-spatial features of neural activity enable decoding of peripheral glucose levels both in the present and up to hours in the future. Our findings demonstrate proactive encoding of homeostatic glucose dynamics by the CNS and highlight the possibility of using intracranial electrophysiology to decode peripheral physiologic states.In summary, we show that noninvasive neuromodulation, whether by ultrasonic drug uncaging or TMS, exerts significant effects across entire brain networks in a predictable manner. We also leverage machine learning tools to show that intracranial activity can proactively decode physiologic parameters. Our hope is that these findings can be translated to advance noninvasive neuromodulation for treating both neuropsychiatric conditions and other diseases.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Gene therapy. $3 600619
650 4 $a Fiber optics. $3 535869
650 4 $a Transcranial magnetic stimulation. $3 3686665
650 4 $a Electroconvulsive therapy. $3 657596
650 4 $a Nanoparticles. $3 605747
650 4 $a Brain research. $3 3561789
650 4 $a General anesthesia. $3 3703836
650 4 $a Genetic engineering. $3 530509
650 4 $a Drugs. $3 617161
650 4 $a Psychosis. $3 3292527
650 4 $a Glucose. $3 2084335
650 4 $a Mental depression. $3 3556007
650 4 $a Nervous system. $3 672432
650 4 $a Deep brain stimulation. $3 3703837
650 4 $a Electric currents. $3 868393
650 4 $a Reproducibility. $3 3683754
650 4 $a Ultrasonic imaging. $3 828386
650 4 $a Bioengineering. $3 657580
650 4 $a Clinical psychology. $3 524863
650 4 $a Genetics. $3 530508
650 4 $a Medical imaging. $3 3172799
650 4 $a Mental health. $3 534751
650 4 $a Nanotechnology. $3 526235
650 4 $a Neurosciences. $3 588700
650 4 $a Optics. $3 517925
650 4 $a Psychology. $3 519075
650 4 $a Surgery. $3 707153
650 4 $a Therapy. $3 3343697
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0202
690 $a 0622
690 $a 0369
690 $a 0574
690 $a 0347
690 $a 0652
690 $a 0317
690 $a 0752
690 $a 0621
690 $a 0576
690 $a 0212
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a Stanford University. $3 754827
773 0 $t Dissertations Abstracts International $g 85-04A.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30615148 $z click for full text (PQDT)